TruAlt Bioenergy FY26 PAT ₹9,686.98 Cr; Q4 Profit Falls

2 min read     Updated on 23 May 2026, 01:18 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

TruAlt Bioenergy announced its audited financial results for the quarter and year ended March 31, 2026, reporting a consolidated PAT of ₹9,686.98 crore for FY26. Revenue from operations for the year stood at ₹1,72,750.66 crore. For Q4 FY26, net profit declined to ₹609.50 crore from ₹1,116.94 crore in the prior year, while revenue dropped to ₹595.52 crore. The company cited reduced ethanol lifting by OMCs and delayed court-ordered allocations as key challenges. Despite revenue pressure, Q4 EBITDA margin improved to 19.94%.

powered bylight_fuzz_icon
40756474

*this image is generated using AI for illustrative purposes only.

TruAlt Bioenergy Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone and consolidated financial results at its meeting held on May 22, 2026. The company reported a consolidated Profit After Tax (PAT) of ₹9,686.98 crore for the fiscal year 2025-26, while revenue from operations for the year stood at ₹1,72,750.66 crore. For the quarter ended March 31, 2026, the company recorded a net profit of ₹609.50 crore compared to ₹1,116.94 crore in the same quarter of the previous year, while revenue came in at ₹595.52 crore against ₹906.99 crore year-on-year, reflecting a notable decline across key metrics. The statutory auditors, M/s N. M. Raiji & Co., issued an unmodified opinion on the financial results.

Financial Performance

The company's full-year operational metrics showed variations compared to the previous year. The total comprehensive income for the year was ₹9,710.18 crore, with Earnings per Share (EPS) reported at ₹12.30 on a basic and diluted basis. Finance costs for the year increased to ₹16,002.41 crore from ₹14,361.10 crore in the previous year.

The following table summarises the full-year consolidated financial performance:

Metric: Year Ended March 31, 2026 (₹ crore) Year Ended March 31, 2025 (₹ crore)
Revenue from Operations 1,72,750.66 1,90,772.40
Total Income 1,81,395.91 1,96,852.78
Total Expenses 1,68,400.44 1,80,908.50
Profit for the Year 9,686.98 14,663.85

Q4 Performance Highlights

The quarter ended March 31, 2026 reflected a marked year-on-year contraction across key financial indicators. Net profit stood at ₹609.50 crore compared to ₹1,116.94 crore in the corresponding quarter of the prior year. Revenue declined to ₹595.52 crore from ₹906.99 crore year-on-year. Despite the revenue pressure, EBITDA margin improved to 19.94% from 17.00% year-on-year, even as absolute EBITDA contracted to ₹119.47 crore from ₹153.44 crore in the same period last year.

The key Q4 metrics are summarised below:

Metric: Q4 FY26 Q4 FY25 (YoY)
Net Profit ₹609.50 crore ₹1,116.94 crore
Revenue ₹595.52 crore ₹906.99 crore
EBITDA ₹119.47 crore ₹153.44 crore
EBITDA Margin 19.94% 17.00%

Operational Challenges

The company faced significant headwinds during the quarter due to a sharp reduction in ethanol lifting by Oil Marketing Companies (OMCs). Despite adequate raw material availability and fully operational capacities across its 2,000 KLPD ethanol platform, offtake remained materially below requirements. Performance was further impacted by delays in executing a pending allocation of approximately 15 crore litres following an order from the Hon'ble Karnataka High Court. This pending quantity represents an estimated revenue potential of nearly ₹1,062 crore.

Corporate Developments

During the year, TruAlt Bioenergy developed dual-feed capabilities to mitigate seasonality in the ethanol business, with dual-feed capacities installed at Unit 1, Unit 2, and Unit 4. Sumitomo Corporation acquired a 49% equity interest in TruAlt Gas Private Limited, a subsidiary, in April 2026. The company also entered into an agreement with Honeywell to deploy Ethanol-to-Jet (ETJ) process technology for a sustainable aviation fuel production facility with an envisaged capacity of 80,000 tonnes per annum. The Board approved the appointment of M/s ZADN and Associates LLP as Internal Auditors and M/s R. Nanabhoy & Co. as Cost Auditors for the financial year 2026-27.

How might the resolution of the Karnataka High Court order and the subsequent release of the pending 15 crore litre allocation impact TruAlt Bioenergy's revenue recovery trajectory in FY27?

What strategic role could Sumitomo Corporation's 49% stake in TruAlt Gas Private Limited play in expanding the company's compressed biogas or clean energy footprint in domestic and international markets?

Given the rising finance costs and declining revenue, how sustainable is TruAlt Bioenergy's debt servicing capacity, and could the company pursue equity dilution or asset monetization to strengthen its balance sheet?

like19
dislike

Trualt Bioenergy Limited Files SEBI Regulatory Certificate for Quarter Ended March 31, 2026

1 min read     Updated on 14 Apr 2026, 05:12 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Trualt Bioenergy Limited submitted its quarterly regulatory certificate to BSE and NSE for the quarter ended March 31, 2026, under SEBI Regulation 74(5). The certificate, issued by registrar Bigshare Services Private Limited, confirms the regulation's non-applicability as all company shares remain in demat form with no rematerialization requests during the quarter.

powered bylight_fuzz_icon
37712533

*this image is generated using AI for illustrative purposes only.

Trualt Bioenergy Limited has filed its quarterly regulatory certificate with the Bombay Stock Exchange and National Stock Exchange of India for the quarter ended March 31, 2026. The submission fulfills the company's compliance obligations under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Certificate

The certificate was submitted on April 13, 2026, by Company Secretary and Compliance Officer Monu Kumar. The document pertains to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, which was previously covered under Regulation 54 of the SEBI (Depository and Participant) Regulations, 1996.

Parameter: Details
Filing Date: April 13, 2026
Quarter Period: March 31, 2026
Regulation: SEBI Regulation 74(5)
Registrar: Bigshare Services Private Limited

Certificate Details and Non-Applicability

Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the certificate on April 4, 2026. The registrar confirmed that Regulation 74(5) is not applicable to Trualt Bioenergy Limited for the specified quarter.

The non-applicability stems from two key factors:

  • The entire shareholding of the company remains in dematerialized form
  • No requests were received from shareholders for rematerialization or dematerialization during the quarter ended March 31, 2026

Corporate Information

Trualt Bioenergy Limited is headquartered at Kulali Cross, Jamkhandi, Mudhol, Bagalkot, with PIN code 587313. The company maintains its regulatory compliance through systematic filing of required certificates and documentation with stock exchanges.

The certificate submission represents part of the company's ongoing regulatory obligations to maintain transparency and compliance with SEBI guidelines for listed entities. The digital signature authentication was completed by Company Secretary Monu Kumar on April 13, 2026, at 18:37:44 hours.

What are Trualt Bioenergy's growth plans and capital allocation strategies for the upcoming quarters in 2026?

How might the company's 100% dematerialized shareholding structure impact its future fundraising or M&A activities?

What operational developments or project milestones should investors expect from Trualt Bioenergy in the renewable energy sector?

like17
dislike

More News on Trualt Bioenergy